The import of insulin in dosage forms to Japan shows a decreasing trend from 2024 to 2028, with a consistent reduction in value each year. By 2028, the forecasted value is 312.08 million USD, down from 340.12 million USD in 2024. This reflects a continuous decline in demand or a shift to domestic production solutions. The actual value in 2023 stood higher than the 2024 forecast, indicating a market transition. Analyzing year-on-year variations shows a consistent reduction in imports. The five-year compound annual growth rate (CAGR) indicates a decline in insulin imports, further confirming this downward trajectory.

Future trends to watch for include:

Advancements in domestic insulin production which might further reduce dependency on imports.
Policy changes favoring local manufacturing and their impact on import demands.
Technological advancements potentially reducing the demand for traditional insulin forms.